Delivery Order SPE2DB24D2101-SPE2DB25FKMQV
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,141.35, is for the delivery of 0.5 milliliter Viscoat syringes. The contract is a firm fixed-price delivery order, with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $20,038.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VISCOAT SYRINGE 0.5ML. The delivery order was issued against an undisclosed government-wide acquisition contract vehicle or blanket purchase agreement held by Amerisourcebergen. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by August 28, 2023. No subcontractors or set aside designations were...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order worth $4,083.45 for the supply of Viscoat Syringes 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- This $21,290.28 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL VISCOAT syringes. The order has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities supporting...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,402.80 contract is for the delivery of 0.5mL viscoat syringes to be completed by January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This order is issued under an indefinite delivery contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $7,001.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide 0.5 mL VISCOAT syringes. This delivery order was issued under an existing $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to supply...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,402.80 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 0.5mL VISCOAT syringes. The single day contract runs from August 8 to August 9, 2023, with performance taking place in Conshohocken, Pennsylvania. No additional details were provided about the original solicitation or vehicle. The Defense Logistics Agency Troop Support Medical supports the...
- Amerisourcebergen Drug Corp has received a $2,201.40 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply VISCOAT SYRINGE 0.5ML. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical products from its Conshohocken, Pennsylvania headquarters by October 30, 2023. Amerisourcebergen is a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company. The delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VISCOAT SYRINGE 0.5ML. The $2,384.85 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any major subcontractors. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMQVDelivery Order
The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, vaccines, medical devices, and syringes to support Defense Health Agency requirements and other government healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates capability in managing both large-scale indefinite delivery vehicles and individual delivery orders through open competition, positioning the company as a key supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 7/23/25 |